Mediators and receptors in the resolution of inflammation: Drug targeting opportunities

British Journal of Pharmacology

Volumn 158, Issue 4, 2009, Pages 933-935

  Stewart, A G ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Annexin 1; Docosahexaenoic acid; Eicosapentaenoic acid; Fish oil; Formyl peptide receptor; Lipoxin A4; Protease anti protease balance; Protease activated receptor; Protectins; Resolvins

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; FISH OIL; GLUCOCORTICOID; LIPOCORTIN 1; LIPOXIN;

DRUG SAFETY; DRUG TARGETING; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR BINDING; REGULATORY MECHANISM; REVIEW;

ANIMALS; ANNEXIN A1; ANTI-INFLAMMATORY AGENTS; DRUG DELIVERY SYSTEMS; FATTY ACIDS, OMEGA-3; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOXINS; RECEPTOR, PAR-1; RECEPTORS, FORMYL PEPTIDE; SIGNAL TRANSDUCTION;

EID: 70350126324     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00484.x     Document Type: Review

References (21)

1. Belvisi MG, Mitchell JA (2009). Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease. Br J Pharmacol 158 : 994 1003.
2. Buckingham JC (2006). Glucocorticoids: exemplars of multi-tasking. Br J Pharmacol 147 (Suppl. 1 S258 S268.
3. Chiang N, Schwab JM, Fredman G, Kasuga K, Gelman S, Serhan CN (2008). Anesthetics impact the resolution of inflammation. PLoS One 3 : e1879.
4. D'Acquisto F, Perretti M, Flower RJ (2008). Annexin-A1: a pivotal regulator of the innate and adaptive immune systems. Br J Pharmacol 155 : 152 169.
5. Galliher-Beckley AJ, Williams JG, Collins JB, Cidlowski JA (2008). Glycogen synthase kinase 3beta-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles. Mol Cell Biol 28 : 7309 7322.
6. Greene C, Mcelvaney NG (2009). Proteases and antiproteases in chronic inflammatory lung diseases. Br J Pharmacol 158 : 1048 1058.
7. Kohli P, Levy, B (2009). Resolvins and protectins: mediating solutions to inflammation. Br J Pharmacol 158 : 960 971.
8. Leitch, AE, Haslett, C, Rossi, AG (2009). Cyclin-dependent kinase inhibitor drugs as potential anti-inflammatory and pro-resolution agents. Br J Pharmacol 158 : 1004 1016.
9. Maderna P, Godson C (2009). Lipoxins: revolutionary road. Br J Pharmacol 158 : 947 959.
10. Neyrinck AP, Liu KD, Howard JP, Matthay MA (2009). Protective mechanism of activated protein C in severe inflammatory disorders. Br J Pharmacol 158 : 1034 1047.
11. Nixon G (2009). Sphingolipids in inflammation: pathological implications and potential therapeutic targets. Br J Pharmacol 158 : 982 993.
12. Pace-Asciak C (2009). The hepoxilins and first generation analogs. Br J Pharmacol 158 : 972 981.
13. Perretti M (2007). Glucocorticoids in innnate immunity: more transactivation than transrepression. Blood 109 : 852 853.
14. Perretti M, Dalli J (2009). Exploiting the Annexin A-1 pathway for the development of novel anti-inflammatory therapeutics. Br J Pharmacol 158 : 936 946.
15. Peters, T, Henry, PJ (2009). Protease-activated receptors and prostaglandins in inflammatory lung disease. Br J Pharmacol 158 : 1017 1033.
16. Pugsley MK, Authier S, Curtis MJ (2008). Principles of safety pharmacology. Br J Pharmacol 154 : 1382 1399.
17. Schacke H, Berger M, Rehwinkel H, Asadullah K (2007). Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index. Mol Cell Endocrinol 275 : 109 117.
18. Schäcke H, Zollner TM, Döcke WD, Rehwinkel H, Jaroch S, Skuballa W et al. (2009). Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases. Br J Pharmacol 158 : 1088 1103.
19. Serhan, CN, Chiang, N (2008). Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br J Pharmacol 153 (Suppl. 1 p. s200 215.
20. Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O'Neill LA et al. (2007). Resolution of inflammation: state of the art, definitions and terms. FASEB J 21 : 325 332.
21. Vodovotz Y, Csete M, Bartels J, Chang S, An G (2008). Translational systems biology of inflammation. PLoS Comput Biol 4 : e1000014.